CoChat

The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment

Open access
Pringle, Abbie, Harmer, Catherine J. · 2015 · Dialogues in Clinical Neuroscience

The DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index; 16 of the 83 sources its claims cite were checked for support.

Abstract

Human models of emotional processing suggest that the direct effect of successful antidepressant drug treatment may be to modify biases in the processing of emotional information. Negative biases in emotional processing are documented in depression, and single or short-term dosing with conventional antidepressant drugs reverses these biases in depressed patients prior to any subjective change in mood. Antidepressant drug treatments also modulate emotional processing in healthy volunteers, which allows the consideration of the psychological effects of these drugs without the confound of changes in mood. As such, human models of emotional processing may prove to be useful for testing the efficacy of novel treatments and for matching treatments to individual patients or subgroups of patients.

Overview

CoChat Summary

TL;DR

This review argues that successful antidepressant drug treatment directly modifies biased emotional processing, with mood improvement following later through relearning and social interaction. It synthesizes human behavioral and neuroimaging evidence in depressed patients and healthy volunteers, and proposes these models for early treatment prediction and drug screening.

Key findings

  • The cognitive neuropsychological model holds that antidepressants directly remediate negative emotional processing biases before subjective mood change; for example, a single dose of the SNRI reboxetine reversed negative biases in depressed patients in the absence of changes in subjective mood or anxiety.
  • Early emotional processing changes predict later clinical improvement: increased recognition of happy faces after 2 weeks of reboxetine or citalopram correlated with mood improvement 4 weeks later; neural changes after 2 weeks of escitalopram predicted response 4 weeks later; in older adults, happy face recognition was marginally predictive after 8-week open-label citalopram, becoming significant when social support was included.
  • Healthy volunteer studies show antidepressant modulation of emotional processing: 7 days of SSRI or SNRI treatment increased positive relative to negative emotional recall; 7 days of citalopram reduced recognition of anger, fear, disgust, and surprise; single-dose reboxetine increased happy face recognition; single-dose citalopram showed complex effects, including increased happy recognition and increased fear processing.
  • The model may help screen putative treatments and detect depressogenic effects: aprepitant showed limited, less consistent effects; GSK424887 had negligible effects; rimonabant produced negative emotional memory biases and was withdrawn in 2009 over depressogenic side effects; mirtazapine and agomelatine showed positive effects; ketamine’s rapid effects may involve retroactive interference with existing memories.

Methods

  • Narrative review, not a primary experimental study; it synthesizes human behavioral, pharmacological, and neuroimaging studies in depressed patients and healthy volunteers, plus selected rodent back-translation work.
  • Evidence includes single-dose, 7-day, 2-week, and 8-week treatment studies using tasks of emotional memory, facial expression recognition, dot probe attention, emotion-potentiated startle, and fMRI/amygdala responses.
  • Main analysis is qualitative synthesis of cited findings; no systematic search, meta-analysis, or new data collection is reported.

Limitations

  • Stated: further studies are needed to validate the model with treatments having alternative neurochemical mechanisms; study designs and go/no-go parameters require optimization; the amount of early emotional processing change needed to predict later mood improvement remains to be quantified.
  • Stated: single-dose citalopram findings are mixed, with both increases and decreases in amygdala reactivity reported; amygdala response reliability to fearful faces was only moderate over 90 days, implying longer scans and large samples may be needed.
  • Evident: as a narrative review, it does not systematically assess publication bias, study quality, or heterogeneity, and it reports no primary sample sizes or effect estimates beyond those cited from included studies.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.31887/dcns.2015.17.4/apringle

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

7 Valid · 0 Not valid · 43 Not checked · 25 Own results and interpretations

50 more claims

Create a free account to see all 75 claims and to verify the 67 references still open.

See all claims — free account
  • Probably not a substantial claim. 6
  • It may state two separate claims as one. 14

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 82 references

Research works printed but not linked: 8

  1. Beck AT., 1979, Cognitive Therapy of Depression. New York, NY: Guilford;
  2. Williams JMG., 1988, Cognitive Psychology and Emotional Disorders. Oxford, UK: John Wiley and Sons;
  3. Godlewska BR., 2014, J Psychopharmacol. 28(8 Abstract Supplement): Abstract
  4. Brown GW., 1978, Social Origins of Depression. London, U K: Tavistock Publications;
  5. Gotlib IH., 1979, J Consult Clin Psychol., 47, 86, 10.1037/0022-006x.47.1.86 · doi:10.1037/0022-006x.47.1.86 · Paper page
  6. Drevets WC., 1992, Psychopharmacol Bull., 28, 261
  7. Coupland NJ., 2003, J Psychiatry Neurosci., 28, 452
  8. Deakin JW., 2012, Biol Psychiatry.

Cited by

See all 61

Metadata

Authors
Pringle, A., & Harmer, C. J.
Affiliations
University of Oxford (GB)
Corresponding author
Harmer, Catherine J.
Venue
Dialogues in Clinical Neuroscience
Published
2015-12-31
Volume
17
Issue
4
Pages
477-487
ISSN
  • 1294-8322 (ISSN-L)
  • 1958-5969
OpenAlex
W2259267629
Cited by
61
References
83
Citations by year
2026: 2 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 26 · 2020: 4 · 2019: 8 · 2018: 6 · 2017: 2 · 2016: 2
FWCI
2.40
Type
journal article
Language
en
Open access
Locations
  • Dialogues in Clinical Neuroscience (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
antidepressants, emotional processing, emotional bias, depression, healthy volunteers, treatment response prediction, personalized treatment
MeSH terms
Affect, Animals, Antidepressive Agents, Depression, Depressive Disorder, Emotions, Humans, Memory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment. https://app.cochat.ai/papers/10.31887/dcns.2015.17.4/apringle
The paper
Pringle, A., & Harmer, C. J. (2015). The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2015.17.4/apringle

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.